Moderna has reported preliminary clinical results with a bivalent version of its COVID-19 vaccine that combines its original version with another targeting the Beta variant, and seems to offer ...
A study of “cross vaccinations” for COVID-19 found that while side effects are more prevalent when different vaccines are used for booster shots, the antibody level also increases. A panel of ...
With COVID-19 vaccinations ramping up to a fourth dose (i.e., second booster), you may want to consider a booster from the company you didn’t get your initial vaccination from, especially if you ...
Moderna stock surged Thursday after the Covid vaccine-maker beat Wall Street's quarterly expectations, including turning around a surprise profit. Please watch the video at Investors.com - Biotech ...
Moderna stock remains under pressure with analysts projecting steep losses in the fourth quarter. Is MRNA stock a sell in December 2024?
Moderna (MRNA) reported a surprise fourth-quarter profit on Thursday aided by its cost-cutting efforts and some deferred revenue, while the drugmaker reiterated its full-year product sales outlook.
The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot. The new ...
Americans will soon be able to get so-called "mix and match" boosters — an extra COVID-19 shot that's different to the vaccine they originally received. On Wednesday evening, the US Food and ...
Moderna stock remains under pressure with analysts projecting steep losses in the fourth quarter. Is MRNA stock a sell in December 2024? Why I Just Bought More of These 3 Top Dividend Stocks in My ...